These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19526195)

  • 21. Managing severe aggression in frontotemporal dementia.
    Powell A; Flynn P; Rischbieth S; McKellar D
    Australas Psychiatry; 2014 Feb; 22(1):86-9. PubMed ID: 24176944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Life-threatening hypoglycemia attributable to haloperidol in a patient with schizophrenia.
    Couto J; Dos Santos LP; Mendes T; López R
    Braz J Psychiatry; 2019; 41(2):190-191. PubMed ID: 30942323
    [No Abstract]   [Full Text] [Related]  

  • 23. Haloperidol-Associated Uterine Dystonia.
    Ridout KK; Ridout SJ
    Am J Psychiatry; 2017 Mar; 174(3):296. PubMed ID: 28245696
    [No Abstract]   [Full Text] [Related]  

  • 24. A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation.
    MacDonald K; Wilson M; Minassian A; Vilke GM; Becker O; Tallian K; Cobb P; Perez R; Galangue B; Feifel D
    J Clin Psychopharmacol; 2012 Jun; 32(3):317-22. PubMed ID: 22544013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol.
    Giegling I; Drago A; Dolžan V; Plesničar BK; Schäfer M; Hartmann AM; Sander T; Toliat MR; Möller HJ; Stassen HH; Rujescu D; Serretti A
    Pharmacogenet Genomics; 2011 Apr; 21(4):206-16. PubMed ID: 20859245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A biological basis for the sex bias of antipsychotic drugs adverse events.
    Gurwitz D; Morag A; Oved K
    J Am Geriatr Soc; 2013 Aug; 61(8):1437. PubMed ID: 23937507
    [No Abstract]   [Full Text] [Related]  

  • 27. Haloperidol should be used sparingly.
    Skrobik Y
    Crit Care Med; 2002 Nov; 30(11):2613-4; author reply 2614. PubMed ID: 12441793
    [No Abstract]   [Full Text] [Related]  

  • 28. Hyperhidrosis under combination of zotepine and haloperidol alleviated by aripiprazole.
    Huang WL; Chang LR
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):245. PubMed ID: 22443252
    [No Abstract]   [Full Text] [Related]  

  • 29. Antipsychotic-induced paroxysmal perceptual alteration.
    Uchida H; Suzuki T; Watanabe K; Yagi G; Kashima H
    Am J Psychiatry; 2003 Dec; 160(12):2243-4. PubMed ID: 14638603
    [No Abstract]   [Full Text] [Related]  

  • 30. [Deterioration of schizoaffective disorder due to an interaction between haloperidol and carbamazepine].
    Schalekamp T
    Ned Tijdschr Geneeskd; 2003 Feb; 147(8):365; author reply 365. PubMed ID: 12661128
    [No Abstract]   [Full Text] [Related]  

  • 31. Myoclonic and generalized tonic clonic seizures during combined treatment with low doses of clozapine and haloperidol.
    Haberfellner EM
    Eur Psychiatry; 2002 Mar; 17(1):55-6. PubMed ID: 11918994
    [No Abstract]   [Full Text] [Related]  

  • 32. Marked improvement of tardive dystonia after replacing haloperidol with risperidone in a schizophrenic patient.
    Yoshida K; Higuchi H; Hishikawa Y
    Clin Neuropharmacol; 1998; 21(1):68-9. PubMed ID: 9579290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very low-dose neuroleptic treatment in two patients with agitation associated with Alzheimer's disease.
    Risse SC; Lampe TH; Cubberley L
    J Clin Psychiatry; 1987 May; 48(5):207-8. PubMed ID: 2883174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine vs haloperidol for treatment of schizophrenia.
    Glazer WM
    JAMA; 2004 Mar; 291(9):1064-5; author reply 1065-6. PubMed ID: 14996766
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial.
    Asadollahi S; Heidari K; Hatamabadi H; Vafaee R; Yunesian S; Azadbakht A; Mirmohseni L
    Int Clin Psychopharmacol; 2015 May; 30(3):142-50. PubMed ID: 25500684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary retention with venlafaxine-haloperidol combination.
    Benazzi F
    Pharmacopsychiatry; 1997 Jan; 30(1):27. PubMed ID: 9065967
    [No Abstract]   [Full Text] [Related]  

  • 37. [Not Available].
    Muheim L
    Praxis (Bern 1994); 2017; 106(6):328-329. PubMed ID: 28299999
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypotension associated with intravenous haloperidol and imipenem.
    Franco-Bronson K; Gajwani P
    J Clin Psychopharmacol; 1999 Oct; 19(5):480-1. PubMed ID: 10505596
    [No Abstract]   [Full Text] [Related]  

  • 39. A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease.
    Devanand DP; Sackeim HA; Brown RP; Mayeux R
    Arch Neurol; 1989 Aug; 46(8):854-7. PubMed ID: 2667504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal haloperidol therapy associated with dyskinesia in a newborn.
    Collins KO; Comer JB
    Am J Health Syst Pharm; 2003 Nov; 60(21):2253-5. PubMed ID: 14619120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.